MIAT-DHX9的时空表达驱动静脉新极端增生,通过核静止和线粒细胞进展
Yue Lou1, Wen-Hao Tian2, Jia-Long Cui1
1Institute of Mechanobiology & Medical Engineering, School of Life Sciences & Biotechnology, Shanghai Jiao Tong University, Shanghai, China.
Cell reports
|November 19, 2025
概括
MIAT-DHX9轴调节光滑肌肉细胞 (SMC) 增殖和核细胞平衡. 准这一轴可以抑制新极度增生症,为血管干预提供了一种新的治疗策略.
科学领域:
- 血管生物学 血管生物学
- 细胞和分子医学是细胞和分子医学.
- 生物化学 生化学
背景情况:
- 静脉新极度增生 (NIH) 导致血管狭窄和治疗失败.
- 异常的光滑肌肉细胞 (SMC) 增殖驱动NIH.
- 了解NIH病原体对于开发有效疗法至关重要.
研究的目的:
- 调查DExH盒子酶9 (DHX9) 和心肌梗塞相关转录 (MIAT) 在SMC扩散和NIH中的作用.
- 阐明MIAT-DHX9轴的时空核表达和功能.
- 探索针对NIH治疗的MIAT-DHX9轴的潜力.
主要方法:
- 多超分辨率成像和单分子FISH可视化DHX9和MIAT.
- 通过CRISPR介导的基因激活和淘汰来操纵MIAT和DHX9.
- 细胞周期分析和DNA损伤测定,以评估细胞效应.
- 深度学习用于识别核细胞形态生物标志物.
- 活体和动物模型来评估治疗疗效.
主要成果:
- 在S阶段,DHX9在SMC中表现出暂时的核细胞定位.
- MIAT激活促进DHX9核细胞定位,PARP1相互作用和SMC扩散.
- MIAT和DHX9的枯竭会导致核细胞失调,线粒体缺陷和DNA损伤.
- 核细胞形态被确定为细胞状态的潜在生物标志物.
- 在模型中,MIAT-DHX9 Knockdown抑制了SMC增殖和内增生.
结论:
- MIAT-DHX9轴是SMC核细胞平衡和细胞周期进展的关键调节器.
- 这个轴在新极度增生症的发病过程中起着至关重要的作用.
- 针对MIAT-DHX9轴提供了一个新的以核细胞为中心的治疗策略,用于预防/治疗NIH.
更多相关视频
06:14Murine Aortic Crush Injury: An Efficient In Vivo Model of Smooth Muscle Cell Proliferation and Endothelial Function
Published on: June 11, 2017
8.7K
07:02A Rabbit Venous Interposition Model Mimicking Revascularization Surgery using Vein Grafts to Assess Intimal Hyperplasia under Arterial Blood Pressure
Published on: May 15, 2020
6.2K
相关概念视频
Regulation of Angiogenesis and Blood Supply
3.3K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.3K
Mechanism of Angiogenesis
6.6K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.6K
